Trademarkia Logo

Canada

C$
Trademark Search in Canada
SPEAK YOUR MIGRAINE & DESIGN
SPEAK YOUR MIGRAINE & DESIGN
REGISTERED

on 6 Apr 2022

Last Applicant/ Owned by

NOVARTIS AG

4002 Basel

CH

Serial Number

1930931 filed on 16th Nov 2018

Registration Number

TMA1125292 registered on 6th Apr 2022

Registration expiry Date

6th Apr 2032

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

SPEAK YOUR MIGRAINE & DESIGN

Trademark usage description

pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, Read More

Vienna Information


20 . 5 . 7

Plans, schematic drawings, diagrams, curves, outlinesPlans, schémas, diagrammes, courbes, tracés

26 . 11 . 2

Two lines or bandsDeux lignes ou bandes

26 . 11 . 6

Thick lines, bandsLignes épaisses, bandes

26 . 11 . 8

Horizontal lines or bandsLignes ou bandes horizontales

26 . 11 . 13

Wavy lines or bands, zigzag lines or bandsLignes ou bandes ondulées, en dents de scie

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 8

Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.

27 . 5 . 14

Letters repeated by mirror effect or symmetrically in any positionLettres répétées par effet de miroir ou symétriquement dans une position quelconque

29 . 1 . 1

Red, pink, orangeRouge, rose, orangé

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; anti-inflammatories; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue disease, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for prevention and treatment of ocular disorders and diseases; anti-infectives, anti-bacterials, antivirals, anti-biotics, systemic and topical antifungals.


Classification kind code

11

Class [044]
Medical services namely providing medical information to health care professionals and patients in the field of pharmaceuticals and clinical trials


Classification kind code

11

Mark Details


Serial Number

1930931

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 191
on 23rd Mar 2022
Registration Fee Notice Sent
Submitted for opposition 42
on 5th Jan 2022
Advertised
Submitted for opposition 26
on 13th Dec 2021
Approved
Submitted for opposition 27
on 13th Dec 2021
Approval Notice Sent
Submitted for opposition 22
on 28th Jun 2021
Search Recorded
Submitted for opposition 20
on 28th Jun 2021
Examiner's First Report
Submitted for opposition 67
on 11th Sept 2019
Agent Name Changed
Submitted for opposition 31
on 20th Nov 2018
Formalized
Submitted for opposition 1
on 19th Nov 2018
Created
Submitted for opposition 30
on 16th Nov 2018
Filed